Target intelligence / Profile preview

ATP10A divergent transcript (ATP10A-DT)

Target
ATP10A-DT
01

Overview

ATP10A-DT is referred to as a "divergent transcript" associated with the ATP10A gene, but no detailed scientific information is available about its molecular function, classification, or biological role. The ATP10A gene itself encodes an aminophospholipid-transporting ATPase (also called a phospholipid flippase) involved in translocating phospholipids such as phosphatidylcholine across the plasma membrane, affecting membrane dynamics and cell signaling. However, the term "ATP10A-DT" does not appear to refer to the canonical protein target (ATP10A) and instead may refer to a long non-coding RNA (lncRNA) or other noncoding transcript that is transcribed in the opposite (divergent) direction from the ATP10A gene locus. There is no evidence in the current literature that "ATP10A-DT" is a protein-coding gene, therapeutic target, or even a well-characterized molecular entity. "ATP10A-DT" likely represents a bioinformatic or transcriptomic entry (e.g., from BioGPS or similar databases), not a validated therapeutic target or functional protein/gene product. For clinical, pharmacological, or translational research, the correct target is ATP10A (ATPase phospholipid transporting 10A), not "ATP10A-DT". The latter remains poorly characterized and should be flagged as "is_incorrect" for the purposes of target databases or therapeutic research.

Beyond the preview

Go deeper on ATP10A divergent transcript (ATP10A-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP10A divergent transcript (ATP10A-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call